LBP: A Potential Drug Target for Various Diseases (G3929)

Target Name: LBP

NCBI ID: G3929

Content of Review Report on LBP Target / Biomarker

LBP

LBP: A Potential Drug Target for Various Diseases

LBP (LBP_HUMAN), also known as human legionellosis protein, is a protein that is expressed in the human body and has been identified as a potential drug target or biomarker for the treatment of various diseases. LBP is a cytoskeletal protein that is involved in the regulation of cell shape and movement. It is found in various tissues throughout the body, including the lungs, heart, kidneys, and blood vessels.

Recent studies have shown that LBP can be targeted by small molecules, which suggests that it may be an attractive drug target. LBP has a unique structure that allows it to interact with small molecules in a specific way, which could make it an efficient target for drugs that are effective against LBP.

One of the reasons why LBP is considered a potential drug target is its involvement in various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases. LBP has been shown to be involved in the regulation of cell division, which is a key factor in the development and progression of many diseases.

In addition, LBP has also been shown to play a role in modulating the immune response. It has been shown to interact with immune cells and to regulate the release of immune cells from the body. This suggests that LBP may be a useful target for drugs that are designed to enhance or suppress the immune response.

Another potential reason why LBP may be a drug target is its role in the regulation of cell signaling pathways. LBP has been shown to interact with a variety of signaling molecules, including tyrosine kinases and G-protein-coupled receptors. This suggests that LBP may be involved in the regulation of cellular signaling pathways, which could make it a useful target for drugs that are designed to disrupt these pathways.

In addition, LBP has also been shown to play a role in the regulation of cell adhesion. It has been shown to interact with cell adhesion molecules, which are important for the stickiness of cells to surrounding tissues. This suggests that LBP may be involved in the regulation of cell adhesion, which could make it a useful target for drugs that are designed to disrupt this process.

Overall, LBP is a protein that has been shown to be involved in a variety of cellular processes that are important for the development and progression of many diseases. Its unique structure and involvement in cellular signaling pathways, immune response, and cell adhesion make it an attractive target for small molecules. Further research is needed to fully understand the role of LBP as a drug target and to develop effective treatments for the various diseases that are associated with its involvement.

Protein Name: Lipopolysaccharide Binding Protein

Functions: Plays a role in the innate immune response. Binds to the lipid A moiety of bacterial lipopolysaccharides (LPS), a glycolipid present in the outer membrane of all Gram-negative bacteria (PubMed:7517398, PubMed:24120359). Acts as an affinity enhancer for CD14, facilitating its association with LPS. Promotes the release of cytokines in response to bacterial lipopolysaccharide (PubMed:7517398, PubMed:24120359)

The "LBP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LBP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets